Cita APA

Riancho Zarrabeitia, L., Martínez Taboada, V. M., Rúa-Figueroa, I., Alonso, F., Galindo-Izquierdo, M., Ovalles, J., . . . Galisteo, C. (2020). Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.

Citación estilo Chicago

Riancho Zarrabeitia, Leyre, et al. Antiphospholipid Syndrome (APS) in Patients With Systemic Lupus Erythematosus (SLE) Implies a More Severe Disease With More Damage Accrual and Higher Mortality. 2020.

Cita MLA

Riancho Zarrabeitia, Leyre, et al. Antiphospholipid Syndrome (APS) in Patients With Systemic Lupus Erythematosus (SLE) Implies a More Severe Disease With More Damage Accrual and Higher Mortality. 2020.